Skip to main content
Log in

Predictive Effect of Mean Platelet Volume in Patients with Portal Vein Thrombosis: A Meta-analysis of Case-control Studies

  • Published:
Current Medical Science Aims and scope Submit manuscript

Summary

Mean platelet volume (MPV) is an early marker of platelet activation. Larger platelets, compared to small ones, increase platelet adhesion and aggregation, and present a higher thrombotic activity. Some studies have explored the association between MPV and the morbidity of portal vein thrombosis (PVT). The aim of this study was to evaluate the predictive effect of MPV in patients with PVT by a meta-analysis. We searched Pubmed, Web of Science, SCOPUS, OVID, CNKI and CBMD from database inception to September 13,2017. Seven studies in accordance with selection criteria were included. The extraction of basic data was independently conducted by two reviewers. The mean difference in MPV between PVT patients and controls were pooled with weighted mean difference (WMD) and 95% confidence interval of 0.88 fl (95% CI: 0.61-1.15). A random-effect model was chosen for an obvious heterogeneity in the pooling (Chi-square=27.12, df=6, P<000l, I2=77.9%). The sources of heterogeneity were from the difference of primary disease of participants and portal vein diameter. Taken together, our results reveal that MPV is a predictive indicator in patients with PVT.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Qi X, Han G, Fan D. Management of portal vein thrombosis in liver cirrhosis. Nat Rev Gastroenterol Hepatol, 2014, 11(7):435–446

    Article  PubMed  CAS  Google Scholar 

  2. Parikh S, Shah R, Kapoor P. Portal vein thrombosis. Am J Med, 2010, 123(2):111–119

    Article  PubMed  Google Scholar 

  3. Maruyama H, Okugawa H, Takahashi M, et al. De novo portal vein thrombosis in virus-related cirrhosis: predictive factors and long-term outcomes. Am J Gastroenterol, 2013, 108(4):568–574

    Article  PubMed  Google Scholar 

  4. Zocco MA, Di Stasio E, De Cristofaro R, et al. Thrombotic risk factors in patients with liver cirrhosis: correlation with MELD scoring system and portal vein thrombosis development. J Hepatol, 2009, 51(4):682–689

    Article  PubMed  Google Scholar 

  5. Francoz C, Belghiti J, Vilgrain V, et al. Splanchnic vein thrombosis in candidates for liver transplantation: usefulness of screening and anticoagulation. Gut, 2005, 54(5):691–697

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  6. Amitrano L, Guardascione MA, Brancaccio V, et al. Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis. J Hepatol, 2004, 40(5):736–741

    Article  PubMed  Google Scholar 

  7. Cagin YF, Atayan Y, Erdogan MA, et al. Incidence and clinical presentation of portal vein thrombosis in cirrhotic patients. Hepatobiliary Pancreat Dis Int, 2016, 15(5):499–503

    Article  PubMed  Google Scholar 

  8. Fujiyama S, Saitoh S, Kawamura Y, et al. Portal vein thrombosis in liver cirrhosis: incidence, management, and outcome. BMC Gastroenterol, 2017, 17(1):112

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  9. Qi X, Chen H, Han G. Effect of antithrombin, protein C and protein S on portal vein thrombosis in liver cirrhosis: a meta-analysis. Am J Med Sei, 2013, 346(1):38–44

    Article  Google Scholar 

  10. Pellicelli AM, D’Ambrosio C, Barbara G, et al. Clinical and Genetic factors associated to development of portal vein thrombosis in cirrhotic patients without hepatocellular carcinoma. J Hepatol, 2011, 54 (Suppl 1):S77

    Article  Google Scholar 

  11. Mangia A, Villani MR, Cappucci G, et al. Causes of portal venous thrombosis in cirrhotic patients: the role of genetic and acquired factors. Eur J Gastroenterol Hepatol, 2005, 17(7):745–51

    Article  PubMed  CAS  Google Scholar 

  12. Colkesen Y, Muderrisoglu H. The role of mean platelet volume in predicting thrombotic events. Clin Chem Lab Med, 2012, 50(4):631–634

    Article  PubMed  CAS  Google Scholar 

  13. Bath PM, Butterworth RJ. Platelet size: measurement, physiology and vascular disease. Blood Coagul Fibrinolysis, 1996, 7(2):157–161

    Article  PubMed  CAS  Google Scholar 

  14. Jakubowski JA, Adler B, Thompson CB, et al. Influence of platelet volume on the ability of prostacyclin to inhibit platelet aggregation and the release reaction. J Lab Clin Med, 1985, 105(2):271–276

    PubMed  CAS  Google Scholar 

  15. Thompson CB, Jakubowski JA, Quinn PG, et al. Platelet size as a determinant of platelet function. J Lab Clin Med, 1983, 101(2):205–213

    PubMed  CAS  Google Scholar 

  16. Bath PM. The routine measurement of platelet size using sodium citrate alone as the anticoagulant. Thromb Haemost, 1993, 70(4):687–690

    PubMed  CAS  Google Scholar 

  17. Cemin R, Donazzan L, Lippi G, et al. Blood cells characteristics as determinants of acute myocardial infarction. Clin Chem Lab Med, 2011, 49(7):1231–1236

    Article  PubMed  CAS  Google Scholar 

  18. Zandecki M, Genevieve F, Gerard J, et al. Spurious counts and spurious results on haematology analysers: a review. Part I: platelets. Int J Lab Hematol, 2007, 29(1):4–20

    PubMed  CAS  Google Scholar 

  19. Kilicli-Camur N, Demirtunc R, Konuralp C, et al. Could mean platelet volume be a predictive marker for acute myocardial infarction? Med Sei Monit, 2005, 1 l(8):Cr387–392

    Google Scholar 

  20. Greisenegger S, Endler G, Hsieh K, et al. Is elevated mean platelet volume associated with a worse outcome in patients with acute ischemic cerebrovascular events? Stroke, 2004, 35(7):1688–1691

    Article  PubMed  CAS  Google Scholar 

  21. Pizzulli L, Yang A, Martin JF, et al. Changes in platelet size and count in unstable angina compared to stable angina or non-cardiac chest pain. Eur Heart J, 1998, 9(1):80–84

    Article  Google Scholar 

  22. Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and metaanalyses: the PRISMA statement. Int J Surg, 2010, 8(5):336–341

    Article  PubMed  Google Scholar 

  23. Aliosmanoglu I, Gui M, Oguz A, et al. Can mean platelet volume be a new risk factor in portal venous thrombosis? Clin Appl Thromb Hemost, 2013, 19(4):433–436

    Article  PubMed  Google Scholar 

  24. Abdel-Razik A, Mousa N, Elhelaly R, et al. De-novo portal vein thrombosis in liver cirrhosis: risk factors and correlation with the model for end-stage liver disease scoring system. Eur J Gastroenterol Hepatol, 2015, 27(5):585–592

    Article  PubMed  Google Scholar 

  25. Qian YY, Li K. The early prevention and treatment of PVST after laparoscopic splenectomy: A prospective cohort study of 130 patients. Int J Surg, 2017, 44:147–151

    Article  PubMed  Google Scholar 

  26. Girleanu I, Trifan A, Cojocariu C, et al. Platelet indices in patients with de novo portal vein thrombosis and liver cirrhosis. Rev Med Chir Soc Med Nat Iasi, 2013, 117(3):641–647

    PubMed  Google Scholar 

  27. He S, He F. Predictive model of portal venous system thrombosis in cirrhotic portal hypertensive patients after splenectomy. Int J Clin Exp Med, 2015, 8(3):4236–4242

    PubMed  PubMed Central  CAS  Google Scholar 

  28. He S, Fan X, Shi X, et al. Risk factors for portal vein thrombosis after splenectomy for portal hypertension due to liver cirrhosis and establishment of its prediction model. Chin J General Surg (Chinese), 2016, 25(12):1766–1772

    Google Scholar 

  29. Zhang Q, Guo LY. Analysis of risk factors for portal vein thrombosis in cirrhosis. Med Philosop (Chinese), 2015, 12:32–34

    Google Scholar 

  30. Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions. The Cochrane Collaboration, 2011. Available from www. handbook, cochrane. org.

    Google Scholar 

  31. Dickson BC. Virchow’s triad. Br J Haematol, 2009, 145(3):433

    Article  PubMed  Google Scholar 

  32. Beyazit Y, Sayilir A, Torun S, et al. Mean platelet volume as an indicator of disease severity in patients with acute pancreatitis. Clin Res Hepatol Gastroenterol, 2012, 36(2):162–168

    Article  PubMed  Google Scholar 

  33. Gasparyan AY, Ayvazyan L, Mikhailidis DP, et al. Mean platelet volume: a link between thrombosis and inflammation? Curr Pharm Des, 2011, 17(1):47–58

    Article  PubMed  CAS  Google Scholar 

  34. Grove EL, Hvas AM, Mortensen SB, et al. Effect of platelet turnover on whole blood platelet aggregation in patients with coronary artery disease. J Thromb Haemost, 2011, 9(1):185–191

    Article  PubMed  CAS  Google Scholar 

  35. Qi X, De Stefano V, Li H, et al. Anticoagulation for the treatment of portal vein thrombosis in liver cirrhosis: a systematic review and meta-analysis of observational studies. Eur J Intern Med, 2015, 26(1):23–29

    Article  PubMed  CAS  Google Scholar 

  36. Amitrano L, Guardascione MA, Menchise A, et al. Safety and efficacy of anticoagulation therapy with low molecular weight heparin for portal vein thrombosis in patients with liver cirrhosis. J Clin Gastroenterol, 2010, 44(6):448–451

    PubMed  CAS  Google Scholar 

  37. Senzolo M, Ferronato C, Burra P, Anticoagulation for portal vein thrombosis in cirrhotic patients should be always considered. Intern Emerg Med, 2009, 4(2):161–162

    Article  PubMed  Google Scholar 

  38. Cao X, Xie X, Zhou J, et al. Increased platelet volume in a general population with prehypertension: a cross-sectional study of 80545 participants from China. Hypertens Res, 2012, 35(9):903–908

    Article  PubMed  Google Scholar 

  39. Ntaios G, Gurer O, Faouzi M, et al. Hypertension is an independent predictor of mean platelet volume in patients with acute ischaemic stroke. Intern Med J, 2011, 41(9):691–695

    Article  PubMed  CAS  Google Scholar 

  40. Nadar SK, Blann AD, Kamath S, et al. Platelet indexes in relation to target organ damage in highrisk hypertensive patients: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT). J Am Coll Cardiol, 2004, 44(2):415–422

    Article  PubMed  Google Scholar 

  41. Tetikoglu M, Aktas S, Sagdik HM, et al. Mean Platelet Volume is Associated with Diabetic Macular Edema in Patients with Type-2 Diabetes Mellitus. Semin Ophthalmol, 2017, 32(5):651–654

    Article  PubMed  Google Scholar 

  42. Shah B, Sha D, Xie D, et al. The relationship between diabetes, metabolic syndrome, and platelet activity as measured by mean platelet volume: the National Health And Nutrition Examination Survey, 1999–2004. Diabetes Care, 2012, 35(5):1074–1078

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgments

We would like to appreciate the researchers and study participants for their contributions.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yu Hu.

Additional information

This work was supported by the National Natural Science Foundation of China (No. 81500109).

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lin, Wy., Lu, X., Fan, Fj. et al. Predictive Effect of Mean Platelet Volume in Patients with Portal Vein Thrombosis: A Meta-analysis of Case-control Studies. CURR MED SCI 38, 575–581 (2018). https://doi.org/10.1007/s11596-018-1916-z

Download citation

  • Received:

  • Revised:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11596-018-1916-z

Key words

Navigation